UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 861177
NEW YORK, NY
Position in FOLD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,056,673
-$4,158,880 QoQ
Shares Held
557,170
-35.0% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. FOLD ranks #48 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in FOLD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,056,673 | 557,170 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $12,215,553 | 857,834 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,484,692 | 822,931 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,195,747 | 1,255,803 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,751,384 | 1,072,474 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $9,030,677 | 958,671 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,198,690 | 486,769 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,298,061 | 534,079 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,959,522 | 251,233 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,658,180 | 257,800 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,991,832 | 246,039 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,408,808 | 271,402 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,009,846 | 271,402 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,048,480 | 249,671 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,306,131 | 220,894 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,915,681 | 271,479 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,547,674 | 269,026 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,228,071 | 279,487 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,727,868 | 285,641 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,131,426 | 324,837 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,107,742 | 314,549 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,652,042 | 288,092 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $21,258,759 | 1,505,578 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,381,250 | 290,534 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,722,056 | 294,595 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||